GoldenGolden
Advanced Search
WRF Capital

WRF Capital

A venture capital firm in Washington that focuses on investing in companies operating in life sciences and enabling technologies developing products arising from research.

Washington Research Foundation is a venture capital firm in Washington that focuses on investing in companies operating in life sciences and enabling technologies developing products arising from research. Founded 1981 in Seattle, Washington, United States, it invests in early stage ventures, late stage ventures, series B, series A, debt financing, and seed. Its portfolio companies include AbSci, A-Alpha Bio,Faraday Pharmaceuticals, and AAVogen. As of March 2020, Washington Research Foundation has made 52 investments. Their most recent investment was on September 24, 2019, when A-Alpha Bio raised $2.8M. Washington Research Foundation has had 11 exits., the most notable of which include Alder Biopharmaceuticals, Omeros, and CSATS.

Timeline

1981
Founded

People

Name
Role
LinkedIn

Beth G. Etscheid

Director ofCommercialization

Jeff Eby

Chief Financial Officer

John Reagh

Manager Business Development & Legal Affairs

Loretta Little

Managing Director

Ronald S. Howell

CEO

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

A-Alpha Bio

AbSci

MDmetrix

Phase Genomics

News

Title
Author
Date
Publisher
Description
BioSpace
June 24, 2021
BioSpace
Accelerator Life Science Partners ("ALSP"), a leading early-stage life science accelerator and investment firm, today announced that it has strengthened its executive leadership team with the promotion of Alice Chen, Ph.D., to executive vice president and the addition of Ronald Howell as Senior Advisor.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.